GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
Tigilanol tiglate is under clinical development by QBiotics Group and currently in Phase I for Adenocarcinoma.
6don MSN
A new study published recently in the journal Gut shows children with Crohn's who were prescribed anti-TNF (tumor necrosis ...
Clinical Features. Basal cell carcinoma (BCC) is the most common malignant eyelid tumor, accounting for 85% of all such tumors. [1] The tumor usually affects adults but may also occur in younger ...
Histamine 2 antagonists and PPIs have largely replaced antacids as primary treatment for most acid-peptic disorders; nevertheless, there is still a role for their use as they are inexpensive ...
Cell biology is the discipline of biological sciences that studies the structure, physiology, growth, reproduction and death of cells. Research in cell biology uses microscopic and molecular tools ...
The risks of untreated ulcerative colitis (UC) are many, affecting not only the gastrointestinal tract but also the eyes, joints, liver, kidneys, heart, and bones. As arguably the more severe form of ...
Dec. 17, 2024 — Researchers developed a fully open-source biomolecular structure prediction model that achieves state-of-the-art performance, at the level of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback